Clinical Software in New York

Kaia Health is a digital therapeutics platform specializing in evidence-based musculoskeletal and chronic pain management. Founded in 2016 with headquarters in Munich and New York City, the company delivers personalized exercise programs via mobile app with real-time feedback, educational content, relaxation modules, and psychological support for conditions including back pain, joint issues, pelvic health, and COPD. Programs are developed by in-house Doctors of Physical Therapy and validated across 11 clinical trials. The platform serves enterprises, health plans, and health systems, covering millions of lives primarily in the US and Europe. With over 560,000 participants, Kaia Health demonstrates clinical outcomes comparable to traditional care and achieves 3x ROI for health plan and employer clients. The non-pharmacological approach emphasizes one-on-one coaching and member engagement with low barriers to access—no appointments or devices required.

Kemtai is a FDA-listed, CE-marked, HIPAA- and GDPR-compliant digital physical therapy platform that delivers AI-guided exercise and assessment software for rehabilitation, physical therapy, and wellness programs. The company develops computer vision technology that analyzes 111 body data points to provide real-time corrective feedback during exercises without requiring sensors or wearables. Kemtai serves health systems, hospitals, rehabilitation centers, payers (insurers, HMOs, value-based care organizations), digital health platforms, and medical device manufacturers. The platform includes Kemtai CARE, a standalone clinician app for managing patients, assigning exercise protocols, ROM assessments, and tracking adherence and performance metrics. Core capabilities include a library of 2,000+ exercises and movement variations, automated patient notifications, in-app messaging, and white-label customization. Integration is available via robust API framework for embedding into third-party platforms. Clinical validation demonstrates 72% average patient adherence, 33% reduction in in-person appointments, and 95% patient satisfaction. The technology is designed for at-home guided rehab, pre-operative therapy, post-operative recovery tracking, and chronic condition management across MSK, cardiac, neurological, and obesity care. Processing occurs on-device with no video recording, ensuring maximum privacy compliance.

LS & S, LLC is a Buffalo, NY-based retailer specializing in assistive devices and adaptive products for individuals with vision loss, hearing loss, and deaf-blind conditions. The company operates an extensive e-commerce platform offering low-vision aids, hearing helpers, daily living aids, and adaptive technology designed to support independence. Product lines include electronic magnifiers (desktop CCTVs, portable handheld units, wearable technology with OCR capabilities), optical magnifiers (stand magnifiers, handheld LED magnifiers, monoculars, binoculars), specialized lighting (daylight lamps, task lighting, magnifying lamps), talking devices (clocks, watches, scales, glucose meters, blood pressure monitors, thermometers), braille products (watches, household items, writing tools), mobility aids (Ambutech canes, support canes), alerting systems for deaf and hard-of-hearing users (Silent Call, Sonic Alert, Clarity, Serene), amplification devices (personal amplifiers, FM systems, TV listening systems), and hearing aid accessories. Additional offerings include educational materials, games adapted for low vision, healthcare monitoring products, telephones for visually and hearing-impaired users, and memory care products. The company distributes brands including NoIR Medical, Schweizer, Walters, Ambutech, and others. LS & S serves the low-vision, deaf, hard-of-hearing, and adaptive living markets through direct online sales with free shipping on orders over $75.

CoachCare is a remote patient monitoring (RPM) and virtual health software platform designed for independent physicians, physician groups, and health systems. The company provides a comprehensive digital health suite combining secure video visits, at-home vital sign capture, digital patient forms, and real-time connected device integration. CoachCare's platform automates clinical workflows, patient engagement, and administrative tasks including scheduling, reporting, and HIPAA-compliant messaging. A core strength is integrated revenue cycle management: the company leverages 35+ years of in-house billing expertise to optimize claims documentation and reimbursement, with customers reporting potential annual RPM reimbursements up to $250,000. The platform serves 150,000+ patients and demonstrates clinical outcomes (e.g., 76.3% average blood pressure reduction). Implementation occurs within two weeks, supported by certified trainers, dedicated implementation coordinators, and ongoing technical support. CoachCare targets outpatient care delivery across primary care, cardiology, and chronic disease management use cases.

Retia Medical Systems develops cardiovascular surveillance software and hemodynamic monitoring solutions for intensive care, operating rooms, and perioperative environments. The company's core offering is the Argos® Cardiac Output Monitor, a bedside hemodynamic monitoring device that derives reliable cardiac output and cardiovascular insight from routine physiologic signals without requiring proprietary disposable sensors. The Argos Infinity™ platform extends this capability enterprise-wide, deploying the company's Multi-Beat Analysis (MBA) algorithm across hospital systems and tele-ICU environments to enable centralized cardiovascular surveillance and analytics. Retia's technology is designed to detect hemodynamic instability earlier than traditional vital sign monitoring, particularly in complex scenarios including arrhythmia, cardiogenic shock, low-flow states, and unstable blood pressure. The software integrates with existing monitoring and tele-ICU platforms, transforming real-time physiologic data into actionable clinical intelligence. Deployed in 75+ hospitals including major academic medical centers (Johns Hopkins, Duke Health, Cleveland Clinic, University Hospitals Cleveland, Texas Health Resources, UMC Health System, Rabin Medical Center), the solution has been validated in 14 peer-reviewed clinical studies. Retia received FDA 510(k) clearance for Argos Infinity. The company targets high-risk populations including cardiac and vascular surgery, sepsis, transplant, trauma, burns, and neurocritical care. Primary value propositions include elimination of disposable sensor costs, intuitive bedside workflow design, and system-wide scalability without infrastructure burden.

Radii Devices Ltd is a UK-based software company founded in 2020 that develops riiForm, a web-based clinical platform for prosthetic and orthotic (P&O) design and fitting. riiForm leverages machine learning and historical patient outcome data to provide evidence-based socket fit recommendations, streamlining the P&O fitting workflow from initial scan through final delivery. The platform supports multiple device types including below-knee prosthetics, above-knee prosthetics (coming soon), and ankle-foot orthoses (AFOs). Key features include automated fit suggestions based on scan analysis and historical data, intuitive digital modification tools, longitudinal patient comparison with limb shape evolution tracking, and compatibility with both carving and 3D printing workflows. The system operates on an episode-of-care pricing model rather than per-export fees, covering the entire fitting journey including multiple check sockets. Radii is ISO 13485:2016 certified for software design and production, FDA-registered as a Medical Device Establishment, and holds CE marking and UKCA marking for Class I medical device classification under UK MDR 2002 and EU MDR 2017/745. The company has completed two clinical studies—a feasibility study (IRAS 313408) and a safety usability evaluation (IRAS 317901)—demonstrating rigorous validation of the Adaptive Templates Fitting System. The team includes award-winning researchers, mechanical engineers, software developers, and human-centered design specialists with over ten years of clinical experience. Radii serves prosthetic clinics globally and has partnered with major organizations including HP Additive Manufacturing Solutions, PVA Med, the U.S. Department of Veterans Affairs, and DASA (Disabled People's Association Singapore).

VasoMedical, Inc. is a cardiovascular technology company with nearly 40 years of experience in cardiac diagnostics and therapy. The company specializes in two primary product areas: Enhanced External Counterpulsation (EECP®) therapy systems and next-generation cardiac monitoring platforms. Their Lumenair™ EECP® system is deployed in over 600 clinics across 40+ countries and is used for non-invasive therapy to improve coronary circulation, helping patients with angina and heart failure improve exercise tolerance and quality of life. In cardiac monitoring, VasoMedical offers the ARCS cloud-native platform, an FDA-cleared system for Holter, Extended Holter, Event, and Multi-Channel Telemetry (MCT) monitoring. ARCS features artifact-reduction algorithms, unified workflow management, and high-volume scanning capabilities designed to reduce manual rework and accelerate turnaround times. The company has analyzed over 1 billion heartbeats and delivered 12+ million hours of cardiac monitoring data. VasoMedical also provides the Advanced Cardiac Therapy (ACT) Program, a comprehensive utilization and operations model to help health systems optimize EECP program performance across cardiology, rehabilitation, and administrative workflows. The company serves hospitals, cardiology practices, rehabilitation clinics, and health systems ranging from private practices to major healthcare networks. Products are supported by FDA clearance for monitoring algorithms and established reimbursement pathways. VasoMedical combines hardware, software, and operational consulting to address both clinical and workflow challenges in cardiac care.

RaySearch Laboratories is a Swedish medical software company specializing in oncology treatment planning and management solutions. The company develops advanced software platforms that enable cancer treatment centers to optimize radiation therapy, chemotherapy, and adaptive care workflows. RaySearch's primary offering is RayCare, an integrated oncology information system designed to support thousands of clinics worldwide. The company collaborates with leading cancer centers to translate scientific advancements into clinical solutions. RaySearch operates in the radiation oncology and comprehensive cancer care software space, serving hospitals and specialized cancer treatment facilities globally. The company is publicly traded (AB publ) and maintains active participation in major oncology conferences including ECIO and IBA's International Symposium on Proton Therapy. Recent expansion includes market entry in China with initial RayCare orders.

TMRW Life Sciences manufactures and operates the world's first FDA-cleared automated platform for specimen management and cryogenic storage of frozen eggs and embryos. The company serves fertility clinics with an integrated digital ecosystem comprising RFID-tracked inventory management, ivfOS software database, 24/7 monitoring via Overwatch®, and flexible storage configurations (onsite/offsite, liquid/vapor phase nitrogen). TMRW's core offering includes automated storage systems (robots and vault solutions), specimen transport with GPS tracking, digital chain-of-custody documentation, and a biorepository service for patients. The platform is designed by embryologists and addresses legacy dewar-based specimen management by consolidating inventory control, reducing operational footprint, and minimizing points of failure by up to 94%. Regulatory credentials include FDA clearance, CE marking, and HIPAA-compliant data security. Target market is fertility clinics ranging from single-site practices to multi-clinic networks. The company emphasizes reduced cryoroom footprint, digitized legacy inventory systems, and real-time specimen visibility. Services include clinic support, patient biorepository options, and ongoing platform monitoring.

Radformation is a healthcare technology company specializing in AI-driven automation software for radiation oncology workflows. Founded in 2016 and based in New York, the company develops intelligent tools that enhance efficiency, reduce errors, and improve cancer treatment planning across oncology clinics. Radformation's integrated platform supports the complete treatment lifecycle—from automated contouring and planning to quality assurance, treatment monitoring, and billing automation. Key offerings include AutoContour (480+ deep-learning anatomical structures), EZFluence (3D automated planning), ClearCheck (plan evaluation), ClearCalc (independent dose calculation), RadMonteCarlo (Monte Carlo calculations), ChartCheck (real-time treatment monitoring), ChartCheck Adaptive (adaptive dose tracking), QuickCode (billing QA), and RadMachine (machine QA). The platform seamlessly integrates with Eclipse™ TPS and supports photon, electron, proton, and brachytherapy modalities. With over 1,400 clinic installations and multiple regulatory clearances, Radformation enables cancer treatment centers to standardize workflows, increase patient throughput, and deliver safer, higher-quality radiation treatments.

Hero is a smart medication management platform founded in 2012 that helps individuals and caregivers manage complex medication regimens. The company offers an all-inclusive subscription service combining a Wi-Fi-enabled smart dispenser device, mobile app, and 24/7 support. The Hero Smart Dispenser automatically sorts and dispenses medications at scheduled times with one-button activation, stores up to a 90-day supply of 10 different medications, and features safety controls including passcode protection and low-pill alerts. The connected Hero app tracks medication schedules, provides dynamic reminders, enables caregiver monitoring, and supports up to 10 additional medications outside the device. Hero is HIPAA-compliant, FDA-registered, and operates on a subscription model starting at $29.99/month with a 30-day money-back guarantee and limited lifetime warranty. The platform collaborates with healthcare providers for Remote Therapeutic Monitoring across 43 states.

Viora Health is a digital health and lifestyle management company that delivers technology-enabled, evidence-based programs for chronic disease prevention and management. The company develops app-supported, educator-led interventions designed to engage patients in lifestyle modification across nutrition, exercise, behavioral health, and social support. Viora's platform targets conditions including prediabetes, type 2 diabetes, obesity, hypertension, and general chronic disease management, with particular emphasis on culturally competent, trauma-informed care and social determinants of health. The company offers both direct-to-patient enrollment through clinical partnerships and B2B solutions for healthcare systems, primary care practices, and community health centers seeking to scale lifestyle medicine without increasing clinical headcount. Viora's programs are validated by multiple NIH-funded randomized controlled trials and have received full CDC recognition for diabetes prevention (National Diabetes Prevention Program). The company is backed by the National Institutes of Health, American Heart Association, CDC, Johnson & Johnson Innovation Fund, and other institutional partners. Clinical outcomes reported include up to 3-point HbA1C improvements, weight loss up to 49 lbs, and 75% stress reduction among program participants. Viora collects longitudinal patient-reported data to inform care decisions, improve appointment adherence, and provide real-time patient engagement between clinical visits.

Get-Grin Inc develops integrated digital dentistry solutions designed for orthodontic and general dental practices. The company offers the Grin Scope®, an FDA-registered intraoral camera providing high-definition visibility for chairside and remote diagnosis. The core platform includes the Grin AI 3D Treatment Tracker, which uses patented computer vision to match 2D intraoral scans to 3D treatment plans with tooth-level accuracy. The tracker is appliance-agnostic and integrates with major aligner and digital braces systems. Get-Grin provides virtual care coordination through Grin Care Specialists, enabling remote patient engagement and support. The broader Grin Ecosystem unifies treatment planning, real-time patient progress monitoring, and virtual consultation capabilities. The platform targets solo and multi-location dental practices, DSOs (Dental Service Organizations), and OSOs (Orthodontic Service Organizations). Get-Grin emphasizes doctor-centric design, transparent pricing, and personalization at scale. The company maintains FDA registration for its Scope device and positions itself in the orthodontic technology market with focus on treatment transparency and outcomes tracking.

Microstructure Imaging, Inc. (MICSI) develops FDA 510(k)-cleared software solutions that enhance MRI image quality through advanced denoising algorithms. The company's primary product, MICSI-RMT (K241121), is a clinical-grade software suite designed to improve diffusion-weighted and functional MRI imaging across neuroimaging and prostate applications. The platform leverages a patented MP-PCA (Marchenko-Pastur Principal Component Analysis) algorithm that reduces noise by approximately 4-fold while preserving anatomical integrity and diagnostic signal fidelity. MICSI-RMT integrates quantitative analysis modules supporting weighted linear least squares and Bayesian fitting techniques for diffusion-weighted imaging, alongside secure DICOM data routing for seamless workflow integration. Key clinical benefits include enhanced image resolution without hardware upgrades, reduced image acquisition requirements (enabling shorter scan times and improved patient comfort), extended operational lifespan of 1.5T and 3.0T MRI systems, and improved diagnostic sensitivity. The software is compatible with standard MRI protocols on GE and other major platforms. Clinical validation is supported by peer-reviewed publications in high-impact journals (Neuroimage, Radiology, Investigative Radiology) and multiple regulatory citations. MICSI targets hospital imaging departments, diagnostic centers, and research institutions seeking cost-effective image quality improvements and operational efficiency gains without capital equipment replacement.

Paige.AI is a clinical AI software company specializing in computational pathology for cancer diagnostics and biomarker discovery. The company develops AI-assisted diagnostic applications and foundation models for histopathology analysis, enabling pathologists to detect, subtype, and identify molecular biomarkers from tissue samples. Core product lines include the Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige PanCancer Suite—all designed to support cancer detection and classification on H&E-stained whole-slide images. The company licenses advanced foundation models (Virchow, Virchow2, Virchow2G, Virchow2G-Mini, and PRISM) to partners for custom AI development in cancer care. Paige Alba is a proprietary co-pilot platform integrating voice and text interfaces with AI diagnostics to streamline pathology workflows. The company provides comprehensive services including custom AI development, regulatory strategy consulting, and commercialization support. Paige's technology is trained cumulatively on over 1.5 million slides and designed to address diagnostic scalability and workload pressures in clinical pathology settings. The firm serves pharmaceutical, life sciences, research, and healthcare provider organizations globally.

SiVIEW SAS is a French software company specializing in AI-assisted vision examination systems for ophthalmology and optometry. The company develops a suite of three integrated software products designed to modernize refraction examinations and vision testing workflows in optical retail, independent optician practices, and medical eye care clinics. The product portfolio includes: SiVIEW Exam (AI-assisted vision examination tool that can delegate testing to trained staff), SiVIEW TéléOpto (remote/telemedicine-enabled refraction system), and SiVIEW SelfRef (patient-autonomous vision testing guided by AI algorithms). All solutions integrate seamlessly with existing refraction equipment from leading manufacturers including Essilor, Huvitz, Nidek, Reichert, Rexxam, Supore, Topcon, and Visionix—no hardware replacement required. The company claims over a decade of R&D and has completed more than 900,000 vision examinations using its platform. Key clinical benefits reported by users include examination completion in 5–10 minutes, reduction of frame rework rates to below 1%, enhanced staff autonomy, and support for independent opticians and small teams. SiVIEW serves 1,000+ retail optical points of sale across Europe and operates in multiple countries, with customer testimonials from France, Norway, and other markets. The software is designed to address operational challenges including medical deserts (geographic access gaps), staff dependency, and prescription accuracy. Regulatory positioning and specific FDA/CE certifications are not mentioned in available content.

FFF Enterprises, Inc. is a specialty pharmaceutical distributor and diversified healthcare company founded in 1988, serving as the nation's most trusted distributor of critical-care products, vaccines, and specialty pharmaceuticals. The company operates a nationwide network in partnership with leading group purchasing organizations (GPOs) and member hospital systems. FFF specializes in vaccine distribution across multiple categories including influenza, COVID-19, RSV, pediatric, adult, and travel vaccines, with real-time inventory management and allocation capabilities. The company distributes specialty pharmaceuticals including branded and generic injectables, with recent product additions including naloxone formulations (ZIMHI), bevacizumab biosimilars (Jobevne), and denosumab biosimilars (Aukelso, Bosaya). FFF operates a 24/7 emergency ordering service and maintains Federal Excise Tax (FET) credit processing for vaccine returns. The company offers short-dated product discounts and maintains stringent supply chain integrity standards through its Guaranteed Channel Integrity™ program to prevent counterfeit pharmaceuticals. FFF operates multiple subsidiary and program divisions including Nufactor (specialty pharmacy), Right Now Inventory (inventory management), In Circle Review (publication/education), BioSupply (vaccine reservation platform), and ODRescue (naloxone access initiative). The organization publishes award-winning healthcare trade publications and provides flu season resources and epidemiological surveillance data to healthcare providers. Distribution capabilities span hospital systems, clinics, and healthcare providers nationwide.

Natural Cycles Nordic AB is a Swedish digital health company that develops and distributes an FDA-cleared, algorithm-based contraceptive app and wearable device system for menstrual cycle tracking, fertility planning, pregnancy monitoring, and perimenopause management. The platform serves over 6 million users globally and is certified in 35+ countries. NC° Birth Control delivers 93% typical-use effectiveness and 98% perfect-use effectiveness—equivalent to oral contraceptives—without hormonal side effects. The system combines basal body temperature monitoring via wearable integration with proprietary machine-learning algorithms that personalize fertility predictions to individual cycle patterns rather than assuming standard 28-day cycles. The company markets multiple integrated modules: NC° Birth Control (contraception), NC° Plan Pregnancy (fertility optimization), NC° Follow Pregnancy (pregnancy tracking), NC° Postpartum (recovery support), and NC° Perimenopause (hormone change management). Natural Cycles holds FDA 510(k) clearance for 8+ years and is backed by 27 peer-reviewed studies. The company emphasizes data privacy compliance, including advanced cybersecurity protections mandated for regulated medical devices. Revenue model is subscription-based (monthly or annual plans) plus device costs, avoiding third-party data monetization. Distributed globally through direct-to-consumer digital channels and supported by clinical advisors including OB-GYN specialists.

SoftSmile is an FDA-cleared orthodontic software and aligner manufacturing company founded in 2019. The company offers VISION, a proprietary AI-powered treatment planning platform designed for digital design and production of clear aligners. VISION automates orthodontic workflows with features including patented tooth segmentation (TrueView), biomechanical force analysis (Phantom), bite management (BiteControl), and real-time collision detection. Treatment plans are developed by board-certified orthodontists and aligner specialists rather than automated algorithms alone, ensuring clinical precision and reduced revision rates. SoftSmile manufactures FDA-cleared multilayer copolymer aligners with customizable trimlines and delivers finished cases within 10 business days. The platform supports integration with CBCT and digital scan workflows. The company serves 4,200+ orthodontists globally, has treated over 100,000 patients, and maintains offices in New York and Abu Dhabi. SoftSmile holds 130+ patents in AI and orthodontic technology.

Eforto Health develops the Eforto® System, a validated medical device and software platform for monitoring muscle strength, muscle fatigability, and self-perceived fatigue as biomarkers of vitality capacity (WHO definition). The company offers a comprehensive solution comprising the Eforto® Vigorimeter (an ergonomic handheld grip strength device with medical-grade pressure sensor and auto-calibration), a guided mobile app with validated protocols, and Eforto® Metrics for remote patient monitoring and insightful reporting. The system completes testing in under 5 minutes and supports self-testing at home with interactive app guidance. Core applications include clinical healthcare (disease management, rehabilitation decision-support), health and fitness (muscle health tracking), and clinical research with customizable protocols. The platform is trusted by major medical institutions including Kansas University Medical Center, Erasmus Medical Center, Radboud UMC, and VU Brussels. All data processing is HIPAA, GDPR, and ISO 27001 compliant with FHIR API interoperability. Clinical validation is published in The Lancet Healthy Longevity and Springer journals.

PharmAdva develops the MedaCube, a clinically validated automatic medication dispenser designed to improve medication adherence for seniors, caregivers, and healthcare providers. The device holds up to a 90-day supply of 16 medications and features audio/visual dispensing alerts, caregiver notifications for missed or late doses, refill alerts, tamper-proof security with metal lock, touchscreen interface, WiFi/cellular connectivity, real-time photo documentation of each dose, and backup battery. The MedaCube has demonstrated industry-leading results in published clinical trials and addresses the estimated $300B annual medication adherence challenge in the U.S. Designed for patients with dementia and aging individuals seeking to maintain independent living, the device integrates cloud-based medication management with no monthly subscription fees. Over 100 million pills have been dispensed using the MedaCube platform since commercial launch in 2016.

Aptar Digital Health, a division of Aptar Pharma and part of AptarGroup, Inc., is a comprehensive digital health solutions provider headquartered in Congers, New York. The company specializes in developing and deploying regulated digital therapeutics, companion mobile applications, and connected drug-delivery systems tailored for pharmaceutical and biotechnology partners globally. Aptar Digital Health operates across 120 countries with 20+ years of digital health leadership, supporting 15+ regulatory approvals and 17+ clinical studies. The platform is ISO 13485 and ISO 27001 certified, MDSAP-compliant, and adheres to HIPAA and GDPR standards. Core offerings include Software as a Medical Device (SaMD), Digital Patient Support Programs (PSPs), Disease Management Platforms, and Real-World Evidence generation services. Therapeutic focus areas encompass oncology, respiratory care, neurology (migraine, multiple sclerosis), immunology, and chronic disease management. The company's integrated platform enables pharmaceutical partners to enhance treatment adherence, optimize patient engagement across the entire treatment journey, and generate actionable clinical insights through connected devices and user community analytics.

Dandy is a fully digital dental laboratory based in New York City serving dental practices across North America. The company provides end-to-end digital dentistry solutions integrating intraoral scanning technology, cloud-based case management software, and advanced CAD/CAM manufacturing. Dandy offers a comprehensive suite of restorative products including zirconia crowns (5-day turnaround), full and partial dentures (2-appointment workflow), implant restorations, clear aligners, splints, guards, and sleep apnea appliances. The company provides practices with free hardware (intraoral scanner and laptop), proprietary chairside scanning software, and live clinical support with real-time case review and technician consultation. Dandy serves 8,000+ dental practices and emphasizes workflow optimization, reduced chair time, and >99% on-time delivery performance.

Plymouth Medical is a Brooklyn-based orthobiologics and regenerative medicine company specializing in evidence-based products and services for healthcare providers across orthopedics, sports medicine, pain management, dermatology, plastics, regenerative esthetics, urology, and OBGYN. The company offers a comprehensive portfolio including platelet-rich plasma (PRP) systems, microfat grafting devices, analgesia systems, hemocytometers, wireless ultrasound probes, and microneedling devices. Beyond product distribution, Plymouth Medical provides clinical staff training, quality control services through PRP analysis and characterization (PAC), patient outcome tracking via the DataBiologics registry, and post-treatment rehabilitation support through digital remote therapeutic monitoring platforms. The company operates with a small core team supported by independent sales representatives across North America, emphasizing ethical guidelines and evidence-based practice in regenerative and orthobiologic treatments.

roclub (Remote Operations Club) is a cloud-based software platform enabling remote operation and support of MRI and CT imaging systems. The company provides a multi-vendor, plug-and-play solution for healthcare organizations to conduct remote scanning (remote operation of MRI/CT devices) and remote support (on-the-job training and technical assistance for radiologic technologists). The platform includes scheduling and planning tools, real-time screen sharing and device control with video conferencing and chat capabilities, and a built-in marketplace (rocStars) for booking external qualified imaging technicians. Core features address workforce management, skill development, and continuous quality assurance through integrated documentation, quality rating systems, and billing functions. The solution supports hybrid work models, on-call coverage, staff shortages, and specialist knowledge sharing across healthcare facility networks. Multi-vendor connectivity supports imaging devices from Siemens, Philips, GE, and Canon without requiring VPN setup. Security architecture includes multi-factor authentication, end-to-end encryption, and continuous cloud monitoring. The company offers roCover, an included liability insurance program for marketplace-booked external personnel. Intended users are health systems, hospital networks, and imaging centers managing MRI/CT operations across multiple locations.

Healthy.io Ltd. develops smartphone-based clinical diagnostic solutions using computer vision, colorimetric analysis, and AI algorithms to enable remote patient testing from home. The company's core offering transforms a patient's smartphone camera into a clinical-grade medical device capable of analyzing urine tests for early detection of kidney disease and chronic wound assessment. The platform is FDA-cleared and CE-marked, featuring seamless EMR integration via SMART on FHIR standards. Products include Minuteful Kidney for home-based kidney function testing and Minuteful Wound for wound care assessment. The company partners with health systems, health plans (including Medica and Blue Cross of Idaho), and wound care providers to improve screening completion rates, advance health equity, and close the care loop with post-test services. The technology operates across varying devices and lighting conditions, achieving 93% patient satisfaction and up to 50% completion rates among previously untested populations. Healthy.io targets at-risk patient populations, rural communities, and healthcare systems seeking to address the gap where 90% of individuals with chronic kidney disease remain undiagnosed.

Emerald Resources Healthcare is a distributor and service provider of specialized medical equipment for long-term care, hospitals, assisted living, and group homes across New York State, Pennsylvania, and New England. With over 30 years of industry experience, the company supplies fall prevention systems, patient lifting and transfer equipment, positioning and seating solutions, patient bathing systems, wandering resident alert systems using active RFID technology, infant protection systems, secure access control, and wireless nurse call systems. Emerald Resources distinguishes itself through local service support with live customer representatives and on-site technicians providing rapid response to equipment needs and maintenance.

BioSignal is a neurodiagnostic company specializing in functional brain assessment via portable EEG technology. The company's FDA-approved microEEG® solution is a miniature, wireless clinical platform enabling rapid electroencephalogram (EEG) recording with cloud-based remote interpretation. BioSignal serves traditional neurology settings (epilepsy centers, sleep labs, neurology departments, ICUs) and expands brain function assessment into novel environments including emergency departments, NICUs, physician offices, ambulances, and home care. The platform supports sports concussion management, traumatic brain injury assessment, routine EEG monitoring, and STAT EEG capabilities. Applications span clinical neurology, emergency medicine, pediatric critical care, sleep medicine, sports medicine, and home sleep monitoring. The solution combines hardware portability with interpretive software to enable rapid assessment and telemedicine-capable EEG interpretation.

Sword Health is a digital health platform providing AI-powered clinical care delivery across musculoskeletal (MSK), women's health, mental health, and cardiometabolic conditions. The company operates a hybrid clinical model combining licensed physical therapists and clinical specialists with proprietary AI Care technology to deliver personalized treatment at scale. Primary offerings include: Thrive (digital physical therapy for pain and MSK conditions with proven surgery reduction and cost savings); Bloom (clinician-led women's health program covering fertility, pelvic health, and menopause); Pulse (cardiometabolic care for blood pressure, weight, glucose, and cholesterol management); Mind (psychologist-led mental health and EAP services); Predict (AI engine for surgical risk identification); and Academy (clinical education content). The platform is FDA-cleared, HIPAA-compliant, HiTrust-certified, Health Canada-approved, and SOC 2 Type II certified. Sword serves health plans, employers, labor unions, and direct-to-consumer members. Reported outcomes include 3:1 average gross ROI, $3,177 annual member savings, 55% surgery avoidance rate among enrolled members, 69% pain-free outcomes, and 9/10 member satisfaction. The company integrates wearable devices and mobile apps for remote patient monitoring and engagement.